Patents by Inventor Jesse Deere

Jesse Deere has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • VACCINATION USING HERPESVIRUS GENOMES IN NUCLEIC ACID FORM
    Publication number: 20220105173
    Abstract: The present invention provides compositions and methods for inducing immune responses in subjects using HV-based vectors that can be grown in single celled organisms and administered in their nucleic acid form.
    Type: Application
    Filed: October 26, 2021
    Publication date: April 7, 2022
    Applicant: The Regents of the University of California
    Inventors: Dennis Hartigan-O'Connor, Peter Barry, Jesse Deere, Joseph Dutra
  • Antisense antibacterial method and compound
    Publication number: 20070049542
    Abstract: A method and antisense compound for inhibiting the growth of pathogenic bacterial cells are disclosed. The compound contains no more than 12 nucleotide bases and has a targeting nucleic acid sequence of no fewer than 10 bases in length that is complementary to a target sequence containing or within 10 bases, in a downstream direction, of the translational start codon of a bacterial mRNA that encodes a bacterial protein essential for bacterial replication. The compound binds to a target mRNA with a Tm of between 50° to 60° C. The relatively short antisense compounds are substantially more active than conventional antisense compounds having a targeting base sequence of 15 or more bases.
    Type: Application
    Filed: May 10, 2006
    Publication date: March 1, 2007
    Inventors: Bruce Geller, Jesse Deere, Patrick Iversen, Dwight Weller
  • Antisense antibacterial method and compound
    Publication number: 20070021362
    Abstract: A method and antisense compound for inhibiting the growth of pathogenic bacterial cells are disclosed. The compound contains no more than 12 nucleotide bases and has a targeting nucleic acid sequence of no fewer than 10 bases in length that is complementary to a target sequence containing or within 10 bases, in a downstream direction, of the translational start codon of a bacterial mRNA that encodes a bacterial protein essential for bacterial replication. The compound binds to a target mRNA with a Tm of between 50° to 60° C. The relatively short antisense compounds are substantially more active than conventional antisense compounds having a targeting base sequence of 15 or more bases.
    Type: Application
    Filed: July 1, 2005
    Publication date: January 25, 2007
    Inventors: Bruce Geller, Jesse Deere, Patrick Iversen